Literature DB >> 11708591

Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.

.   

Abstract

Since October 3, 2001, CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. This report updates findings as of October 31, and includes interim guidelines for the clinical evaluation of persons with possible anthrax. A total of 21 cases (16 confirmed and five suspected) of bioterrorism-related anthrax have been reported among persons who worked in the District of Columbia, Florida, New Jersey, and New York City (Figure 1). Until the source of these intentional exposures is eliminated, clinicians and laboratorians should be alert for clinical evidence of Bacillus anthracis infection. Epidemiologic investigation of these cases and surveillance to detect new cases of bioterrorism-associated anthrax continues.

Entities:  

Mesh:

Year:  2001        PMID: 11708591

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  35 in total

1.  The informatics response in disaster, terrorism, and war.

Authors:  Jonathan M Teich; Michael M Wagner; Colin F Mackenzie; Klaus O Schafer
Journal:  J Am Med Inform Assoc       Date:  2002 Mar-Apr       Impact factor: 4.497

2.  Response to bioterrorism. Terror weapons are regarded as weapons of mass destruction.

Authors:  Meng-Kin Lim
Journal:  BMJ       Date:  2002-02-09

3.  The primary care differential diagnosis of inhalational anthrax.

Authors:  Jonathan L Temte; Andrew R Zinkel
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

4.  Anthrax: a continuing concern in the era of bioterrorism.

Authors:  Stefan Riedel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-07

5.  Comprehensive Laboratory Evaluation of a Highly Specific Lateral Flow Assay for the Presumptive Identification of Bacillus anthracis Spores in Suspicious White Powders and Environmental Samples.

Authors:  Jason G Ramage; Kristin W Prentice; Lindsay DePalma; Kodumudi S Venkateswaran; Sruti Chivukula; Carol Chapman; Melissa Bell; Shomik Datta; Ajay Singh; Alex Hoffmaster; Jawad Sarwar; Nishanth Parameswaran; Mrinmayi Joshi; Nagarajan Thirunavkkarasu; Viswanathan Krishnan; Stephen Morse; Julie R Avila; Shashi Sharma; Peter L Estacio; Larry Stanker; David R Hodge; Segaran P Pillai
Journal:  Health Secur       Date:  2016 Sep-Oct

6.  Bioterrorism - Health emergency preparedness and response.

Authors:  Douglas W Macpherson
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

7.  Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.

Authors:  Puneet K Dewan; Alicia M Fry; Kayla Laserson; Bruce C Tierney; Conrad P Quinn; James A Hayslett; Laura N Broyles; Andi Shane; Kevin L Winthrop; Ivan Walks; Larry Siegel; Thomas Hales; Vera A Semenova; Sandra Romero-Steiner; Cheryl Elie; Rima Khabbaz; Ali S Khan; Rana A Hajjeh; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

8.  Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001.

Authors:  Carolyn M Greene; Jennita Reefhuis; Christina Tan; Anthony E Fiore; Susan Goldstein; Michael J Beach; Stephen C Redd; David Valiante; Gregory Burr; James Buehler; Robert W Pinner; Eddy Bresnitz; Beth P Bell
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

9.  Laboratory response to anthrax bioterrorism, New York City, 2001.

Authors:  Michael B Heller; Michel L Bunning; Martin E B France; Debra M Niemeyer; Leonard Peruski; Tim Naimi; Phillip M Talboy; Patrick H Murray; Harald W Pietz; John Kornblum; William Oleszko; Sara T Beatrice
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

10.  Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001.

Authors:  Christina G Tan; Hardeep S Sandhu; Dana C Crawford; Stephen C Redd; Michael J Beach; James W Buehler; Eddy A Bresnitz; Robert W Pinner; Beth P Bell
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.